For review by 2 July: Weekly ECHA Substance Evaluations

Dear members, please see below MedTech Europe Update, another busy week with the items below highlighted as having previously been identified as potentially used by the MD/IVD sectors. Let me know at regulatory@bivda.org.uk if any of the highlighted items are in your products. Dear members, We hope you are all well. With this email, we would like to inform you…